SR-9009 is a chemical compound from the resveratrol class, belonging to modulators of A1 and A3 adenosine receptor activity. It is more commonly known as Stenabolic and has been mainly researched in the context of enhancing physical performance and fat burning. It is important to note that SR-9009 is not an approved drug for human use but has been studied in animals for its potential effects on metabolic health.
In terms of its action, SR-9009 is associated with the activation of a receptor known as Rev-Erbα, which plays an important role in regulating the circadian rhythm, lipid synthesis, and energy homeostasis. SR-9009 has been suggested to increase fat-burning rates, improve endurance and physical activity, as well as positively affect metabolism.
Although initial studies in animal models have shown promising results, SR-9009 has not been adequately approved or evaluated for human use, and its long-term safety has not been fully established. Therefore, its use outside of research settings remains highly controversial and is not recommended without the supervision of medical professionals.